Aug 14, 2026 06:46AM
Aug 13, 2026 04:04AM
Aug 6, 2026 06:51AM
Jul 22, 2026 06:50AM
Jul 15, 2026 05:11AM
Jun 16, 2026 06:44AM
Jun 15, 2026 06:50AM Pharvaris presents data on deucrictibant for hereditary angioedema treatment
May 13, 2026 05:10AM
May 8, 2026 06:01AM
Apr 20, 2026 06:50AM
Apr 6, 2026 07:10AM
Apr 2, 2026 04:35PM
Mar 20, 2026 06:51AM
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Mar 11, 2026 06:50AM
Mar 9, 2026 05:10AM
Mar 2, 2026 06:55AM
Jan 22, 2026 06:42AM
Jan 12, 2026 06:50AM
Dec 4, 2025 06:55AM
Dec 3, 2025 02:49PM Pharvaris B.V. (PHVS) PT Raised to $38 at Leerink Partners
Dec 3, 2025 11:44AM
Dec 3, 2025 06:50AM
Nov 21, 2025 07:05AM
Nov 19, 2025 04:26AM
Oct 23, 2025 06:44AM
Oct 15, 2025 06:06AM
Oct 8, 2025 04:16PM BofA Securities Upgrades Pharvaris B.V. (PHVS) to Neutral 'on potential label expansion for angioedema treatment'
Aug 13, 2025 04:07AM
Jul 10, 2025 11:17AM
Jul 10, 2025 06:51AM
Jun 27, 2025 06:50AM
Jun 16, 2025 06:50AM
Jun 5, 2025 04:20AM
Jun 2, 2025 06:52AM Pharvaris (PHVS) Presents Data Supporting Ongoing Clinical Development of Deucrictibant
Apr 23, 2025 04:23AM
Apr 1, 2025 06:50AM
Mar 3, 2025 06:50AM
Mar 3, 2025 04:49AM
Feb 18, 2025 04:15AM
Jan 31, 2025 04:40AM
Jan 13, 2025 06:52AM Pharvaris (PHVS) Outlines 2025 Strategic Priorities
Oct 16, 2024 06:51AM
Oct 14, 2024 06:08AM
Oct 3, 2024 06:50AM
Sep 19, 2024 09:33AM
Sep 6, 2024 05:07AM
Sep 5, 2024 06:50AM
Sep 5, 2024 06:50AM Pharvaris (PHVS) Provides Business Update, Expands Development Program for Deucrictibant
Jul 3, 2024 05:54AM

456,315 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All